Home
Clinical Resources Search
PQI: Proactive Symptom Management in Myelofibrosis

Proactive Symptom Management in Myelofibrosis

Last Updated: May 28, 2024

By: Kristyn DiSogra, PharmD, BCOP | Justin Arnall, PharmD, BCOP

About this PQI

The purpose of this PQI is to highlight implementation of telehealth symptom and risk survey completion by pharmacists or other healthcare providers for myelofibrosis (MF) patients.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Hematological Malignancies Myelofibrosis (MF) Myeloproliferative Neoplasm

PQI

Frequently Searched

Supported by

Proactive Symptom Management in Myelofibrosis

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer

PQI in Action: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PQI in Action: Nirogacestat (OGSIVEO®) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)

PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management

PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

S9 E7: A Haven of Healing

S9 E6: Healing Through Sound: A Breast Cancer Journey

S9 E5: Global Health, Cancer Survivorship, and Advancing Equity

S9 E4: Advancing Pharmacogenomics in Oncology

Readiness Tracker

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

S7 Ep 8: Sickle Cell Disease Insights

Ruxolitinib

Pacritinib

Momelotinib

Fedratinib

Ruxolitinib

PQI in Action: Ropeginterferon alfa-2b-njft (BESREMi®) Use in Polycythemia Vera

PQI in Action: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Nirogacestat (Ogsiveo): Treatment Discussion Guide

Vorasidenib

Encorafenib and Binimetinib